From: Boris Nikolic

From: Boris Nikolic To: Jeffrey Epstein <[email protected]> Subject: RE: Dr. Alice Jacobs, CEO of IntelligentMDx, Honored as a 2012 Mass High Tech Woman to Watch Date: Tue, 13 Mar 2012 16:26:01 +0000 Do not underestimate her father. Even now. It will be interesting to watch as they just stop talking so tide might start turning. B From: Jeffrey Epstein [mailto:[email protected]] Sent: Tuesday, March 13, 2012 8:09 AM To: Boris Nikolic Subject: Fwd: Dr. Alice Jacobs, CEO of IntelligentMDx, Honored as a 2012 Mass High Tech Woman to Watch ??????? Forwarded message From: Alice Jacobs < Date: Tue, Mar 13, 2012 at 10:26 AM Subject: Dr. Alice Jacobs, CEO of IntelligentMDx, Honored as a 2012 Mass High Tech Woman to Watch To: Denise Marston < Cambridge, MA, March 6, 2012 — Dr. Alice Jacobs, Chairman and CEO of IntelligentMDx (IMDx), has been named a 2012 Woman to Watch by Mass High Tech. This is the 0 year Mass High Tech, The Voice of New England Innovation, has been honoring New England women for their contributions to their technology sectors and their positions as role models in the community. The Mass High Tech Women to Watch are highly motivated with outstanding records of accomplishment and command attention as they continue to shape the future of their industries. "It is important for young women who aspire to become powerful leaders to have role models to emulate," says Dr. Alice Jacobs. "I am honored to receive this distinction along with other great women." Under the leadership of Dr. Jacobs, IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases. In 2011, IMDx released two CE-marked diagnostic kits, which are being distributed globally by Abbott, targeting two of the most threatening healthcare-associated infections, Clostridium dinette, and vancomycin-resistant enterococci. Diagnostic tests for Group B streptococcus and Influenza MB and RSV are scheduled to obtain CE-marking and launch in the spring of 2012. The IMDx pipeline also includes additional assays targeting oncology, human genetics and companion diagnostics. IMDx employs experts from diverse backgrounds including financial, legal, scientific, and medical, and is run in a unique manner such that all are involved in product development from initial concept stages to commercialization. Dr. Jacobs works hard to ensure the highest quality products are produced at IMDx and accurately reflect the needs of the global medical community. Through the creation of IMDx, Dr. Jacobs is achieving her goal of improving the relationship between patients, physicians and diagnostics. Dr. Jacobs is a woman to watch as IMDx grows and expands its menu offerings, becoming a larger player in the molecular diagnostics industry. EFTA00718974 About IMDx Based in Cambridge, MA, IMDx (www.IntelligentMDx.com) is an innovative company that designs, develops and manufactures molecular diagnostic products. IMDx has developed molecular solutions that are clinically impactful and competitively differentiated for a range of disease areas for current and next generation systems, including targets in infectious diseases, oncology and genetics. IMDx's expertise spans evolutionary biology, bioinformatics, microbiology, chemistry and molecular biology. These capabilities are harnessed by IMDx's proprietary bioinformatics and product development processes allowing for the rapid design and development of tests to meet clinical needs. Alice A. Jacobs, M.D. Chairman & CEO IntelligentMDx 19 Blackstone Street Cambridee. MA 02139 Phone: Cell: Fax: Email: Visit us at www.intelligentMDx.com The information transmitted is intended only for the person or entity to which It is addressed and may contain confidential and/or privileged material. My review. retransmission, dissemination or other use of, or taking of any action in reliance upon, this information by persons or entities other than the intended recipient is prohibited. If you received this in error, please contact the sender and delete the material from all computers. The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00718975